US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

ALX Oncology Holdings

0.5790

+0.054010.29%

Post-market: 0.59000.0110+1.90%19:31 EDT

Volume:967.01K

Turnover:557.64K

Market Cap:30.94M

PE:-0.24

High:0.5900

Open:0.5600

Low:0.5250

Close:0.5250

Loading ...

Overview Company News Filings

Analysts Offer Insights on Healthcare Companies: Tvardi Therapeutics (TVRD) and ALX Oncology Holdings (ALXO)

ALX Oncology Is Maintained at Buy by UBS

UBS Adjusts Price Target on ALX Oncology Holdings to $1 From $1.20, Maintains Buy Rating

MT Newswires Live

ALX Oncology highlights preclinical data, development plans for ALX2004

ALX Oncology Announces Initiation of Phase 1 Clinical Trials for Novel Cancer Therapy ALX2004

ALX Oncology Holdings Inc. Announces FDA Clearance for Investigational New Drug Application of ALX2004

Jefferies Sticks to Their Buy Rating for ALX Oncology Holdings (ALXO)

ALX Oncology Is Maintained at Buy by HC Wainwright & Co.

ALX Oncology Holdings Inc reports results for the quarter ended March 31 - Earnings Summary

ALX Oncology Holdings Q1 Adj. EPS $(0.48) Misses $(0.46) Estimate

BRIEF-ALX Oncology Q1 Basic EPS USD -0.58

ALX Oncology Holdings Inc - Extends Cash Runway Into Q4 2026

THOMSON REUTERS

ALX Oncology Q1 Operating Expenses USD 31.82 Million

THOMSON REUTERS

Calendar of U.S. Earnings Expected in the Week Ahead

ALX Oncology Holdings Inc expected to post a loss of 46 cents a share - Earnings Preview

LifeSci Capital Reaffirms Their Hold Rating on ALX Oncology Holdings (ALXO)

ALX Oncology Phase 1/2 Evorpacept Trial to Treat B-cell Non-Hodgkin Lymphoma Shows Anti-tumor Activity

MT Newswires Live

ALX Oncology reports ‘encouraging’ final results from Phase 1 evorpacept trial

ALX Oncology Announces Encouraging Final Results From Phase 1 Trial Evaluating Evorpacept in Combination With Standard-of-Care Treatment in Patients With B-Cell Non-Hodgkin Lymphoma

THOMSON REUTERS

ALX Oncology Announces Encouraging Final Results from Phase 1 Trial Evaluating Evorpacept in Combination with Standard-of-Care Treatment in Patients with B-cell Non-Hodgkin Lymphoma

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/ALXO/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ALXO","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ALXO\",,,,,undefined,":{"symbol":"ALXO","market":"US","secType":"STK","nameCN":"ALX Oncology Holdings","latestPrice":0.579,"timestamp":1749240000000,"preClose":0.525,"halted":0,"volume":967011,"hourTrading":{"tag":"盘后","latestPrice":0.59,"preClose":0.579,"latestTime":"19:31 EDT","volume":3754,"amount":2180.6277,"timestamp":1749252715917},"delay":0,"floatShares":31342710,"shares":53444020,"eps":-2.453979,"marketStatus":"Closed","change":0.054,"latestTime":"06-06 16:00:00 EDT","open":0.56,"high":0.59,"low":0.525,"amount":557638.8840864,"amplitude":0.12381,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.453979,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1749456000000},"marketStatusCode":5,"adr":0,"listingDate":1594958400000,"exchange":"NASDAQ","adjPreClose":0.525,"preHourTrading":{"tag":"盘前","latestPrice":0.525,"preClose":0.525,"latestTime":"09:13 EDT","volume":52,"amount":27.3,"timestamp":1749215626779},"postHourTrading":{"tag":"盘后","latestPrice":0.59,"preClose":0.579,"latestTime":"19:31 EDT","volume":3754,"amount":2180.6277,"timestamp":1749252715917},"volumeRatio":2.753376,"impliedVol":2.611,"impliedVolPercentile":0.816},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ALXO\",,,,,undefined,":{"symbol":"ALXO","floatShares":31342710,"roa":"-51.16%","roe":"-102.99%","lyrEps":-2.584575,"volumeRatio":2.753376,"shares":53444020,"dividePrice":0,"high":0.59,"amplitude":0.12381,"preClose":0.525,"low":0.525,"week52Low":0.4051,"pbRate":"0.35","week52High":9.3981,"institutionHeld":0,"latestPrice":0.579,"eps":-2.453979,"divideRate":0,"volume":967011,"delay":0,"ttmEps":-2.453979,"open":0.56,"prevYearClose":1.67,"prevWeekClose":0.4855,"prevMonthClose":0.4855,"prevQuarterClose":0.623,"fiveDayClose":0.4855,"twentyDayClose":0.4602,"sixtyDayClose":0.9594},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ALXO\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2537155427","title":"Analysts Offer Insights on Healthcare Companies: Tvardi Therapeutics (TVRD) and ALX Oncology Holdings (ALXO)","url":"https://stock-news.laohu8.com/highlight/detail?id=2537155427","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537155427?lang=en_us&edition=fundamental","pubTime":"2025-05-24 00:30","pubTimestamp":1748017810,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Tvardi Therapeutics (TVRD – Research Report) and ALX...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-tvardi-therapeutics-tvrd-and-alx-oncology-holdings-alxo?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-tvardi-therapeutics-tvrd-and-alx-oncology-holdings-alxo?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HCSG","BK4137","ALXO","ALX","BK4139","BK4080","BK4007","TVRD","BK4231"],"gpt_icon":0},{"id":"2537934578","title":"ALX Oncology Is Maintained at Buy by UBS","url":"https://stock-news.laohu8.com/highlight/detail?id=2537934578","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537934578?lang=en_us&edition=fundamental","pubTime":"2025-05-21 22:49","pubTimestamp":1747838940,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ALXO/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 21, 2025 10:49 ET (14:49 GMT)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALXO","ALX"],"gpt_icon":0},{"id":"2537935969","title":"UBS Adjusts Price Target on ALX Oncology Holdings to $1 From $1.20, Maintains Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2537935969","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537935969?lang=en_us&edition=fundamental","pubTime":"2025-05-21 21:15","pubTimestamp":1747833339,"startTime":"0","endTime":"0","summary":"ALX Oncology Holdings (ALXO) has an average rating of buy and mean price target of $2.25, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from majo","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ALX","ALXO"],"gpt_icon":0},{"id":"2536612781","title":"ALX Oncology highlights preclinical data, development plans for ALX2004","url":"https://stock-news.laohu8.com/highlight/detail?id=2536612781","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536612781?lang=en_us&edition=fundamental","pubTime":"2025-05-20 20:15","pubTimestamp":1747743350,"startTime":"0","endTime":"0","summary":"ALX Oncology (ALXO) Holdings provides an overview of the clinical development program for its highly-differentiated antibody-drug conjugate, ALX200...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/alx-oncology-highlights-preclinical-data-development-plans-for-alx2004?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/alx-oncology-highlights-preclinical-data-development-plans-for-alx2004?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4080","BK4231","ALX","ALXO","BK4139"],"gpt_icon":0},{"id":"2536612843","title":"ALX Oncology Announces Initiation of Phase 1 Clinical Trials for Novel Cancer Therapy ALX2004","url":"https://stock-news.laohu8.com/highlight/detail?id=2536612843","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536612843?lang=en_us&edition=fundamental","pubTime":"2025-05-20 20:00","pubTimestamp":1747742424,"startTime":"0","endTime":"0","summary":"ALX Oncology Holdings Inc. has announced the initiation of its Phase 1 clinical development program for ALX2004, following clearance of its Investigational New Drug  application by the U.S. Food and Drug Administration in April 2025. ALX2004, a novel EGFR-targeted antibody-drug conjugate, is set to enter Phase 1 trials in mid-2025. The trial will focus on dose escalation in patients with EGFR-expressing solid tumors, including non-small cell lung cancer, colorectal cancer, head and neck squamous cell carcinoma, and esophageal squamous cell carcinoma. Initial safety data from the study is anticipated in the first half of 2026. ALX Oncology will provide further details on its clinical development plans and preclinical data in a webcast event. For more information, visit ALX Oncology's website.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250520:nNDLbnWrZ2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210149790.SGD","BK4588","IE00BKPKM429.USD","BK4112","IE00B64PRP62.GBP","ALXO","IE00B3QW5Z07.USD","IE00BGHQF748.EUR","LU2210150020.SGD","NDAQ","BK4139","BK4585","LU2095319765.USD"],"gpt_icon":0},{"id":"2535279227","title":"ALX Oncology Holdings Inc. Announces FDA Clearance for Investigational New Drug Application of ALX2004","url":"https://stock-news.laohu8.com/highlight/detail?id=2535279227","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535279227?lang=en_us&edition=fundamental","pubTime":"2025-05-13 20:00","pubTimestamp":1747137642,"startTime":"0","endTime":"0","summary":"ALX Oncology Holdings Inc., a clinical-stage biotechnology company, announced that it has received clearance for its Investigational New Drug  application from the U.S. Food and Drug Administration for its novel antibody-drug conjugate, ALX2004. This clearance marks a significant step forward in the clinical development of ALX2004, which targets EGFR-expressing tumors and is designed to optimize anti-tumor activity. The IND approval allows ALX Oncology to begin clinical trials to further evaluate the safety and efficacy of ALX2004, which has been fully designed and developed by the company's scientists. The announcement underscores ALX Oncology's commitment to advancing innovative therapies to treat cancer and improve patient outcomes.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpr","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250513:nNDL1jsZr5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2095319765.USD","IE00BKPKM429.USD","IE00B3QW5Z07.USD","IE00B64PRP62.GBP","BK4588","BK4139","NDAQ","LU2210149790.SGD","BK4112","ALXO","IE00BGHQF748.EUR","BK4585","LU2210150020.SGD"],"gpt_icon":0},{"id":"2534409484","title":"Jefferies Sticks to Their Buy Rating for ALX Oncology Holdings (ALXO)","url":"https://stock-news.laohu8.com/highlight/detail?id=2534409484","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534409484?lang=en_us&edition=fundamental","pubTime":"2025-05-09 20:57","pubTimestamp":1746795427,"startTime":"0","endTime":"0","summary":"Jefferies analyst Michael Yee maintained a Buy rating on ALX Oncology Holdings (ALXO – Research Report) yesterday and set a price target of $3.00. ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/jefferies-sticks-to-their-buy-rating-for-alx-oncology-holdings-alxo?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/jefferies-sticks-to-their-buy-rating-for-alx-oncology-holdings-alxo?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ALXO","ALX"],"gpt_icon":0},{"id":"2534079107","title":"ALX Oncology Is Maintained at Buy by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2534079107","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534079107?lang=en_us&edition=fundamental","pubTime":"2025-05-09 19:20","pubTimestamp":1746789600,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ALXO/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 09, 2025 07:20 ET (11:20 GMT)","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALX","ALXO"],"gpt_icon":0},{"id":"2533131959","title":"ALX Oncology Holdings Inc reports results for the quarter ended March 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2533131959","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533131959?lang=en_us&edition=fundamental","pubTime":"2025-05-08 22:15","pubTimestamp":1746713755,"startTime":"0","endTime":"0","summary":"ALX Oncology Holdings Inc reports results for the quarter ended March 31 - Earnings SummaryALX Oncology Holdings Inc ALXO.OQ reported a quarterly adjusted loss of 58 cents per share for the quarter en","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250508:nL8N3RG2B6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALXO"],"gpt_icon":0},{"id":"2533872371","title":"ALX Oncology Holdings Q1 Adj. EPS $(0.48) Misses $(0.46) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2533872371","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533872371?lang=en_us&edition=fundamental","pubTime":"2025-05-08 20:46","pubTimestamp":1746708386,"startTime":"0","endTime":"0","summary":"ALX Oncology Holdings (NASDAQ:ALXO) reported quarterly losses of $(0.48) per share which missed the analyst consensus estimate of $(0.46) by 3.7 percent. This is a 16.32 percent increase over losses of $(0.57) per share","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/05/45284321/alx-oncology-holdings-q1-adj-eps-0-48-misses-0-46-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALX","ALXO"],"gpt_icon":0},{"id":"2533182273","title":"BRIEF-ALX Oncology Q1 Basic EPS USD -0.58","url":"https://stock-news.laohu8.com/highlight/detail?id=2533182273","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533182273?lang=en_us&edition=fundamental","pubTime":"2025-05-08 20:30","pubTimestamp":1746707445,"startTime":"0","endTime":"0","summary":"BRIEF-ALX Oncology Q1 Basic EPS USD -0.58\n\n\nMay 08 (Reuters) - ALX Oncology Q1 operating expenses USD 31.82 million.\n\nQ1 net income USD -30.754 million\nQ1 income from operations USD -31.82 million","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250508:nPLXAF3C43:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALXO"],"gpt_icon":0},{"id":"2533878891","title":"ALX Oncology Holdings Inc - Extends Cash Runway Into Q4 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2533878891","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533878891?lang=en_us&edition=fundamental","pubTime":"2025-05-08 20:30","pubTimestamp":1746707400,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250508:nPLXAF3C43:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ALXO"],"gpt_icon":0},{"id":"2533122182","title":"ALX Oncology Q1 Operating Expenses USD 31.82 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2533122182","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533122182?lang=en_us&edition=fundamental","pubTime":"2025-05-08 20:30","pubTimestamp":1746707400,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250508:nPLXAF3C43:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ALXO","BK4139"],"gpt_icon":0},{"id":"2533055889","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2533055889","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533055889?lang=en_us&edition=fundamental","pubTime":"2025-05-08 18:00","pubTimestamp":1746698400,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIOX","SKIN","AUR","CBLL","ABEO","BN","BBDC","BIGC","DCTH","CADL","AXGN","CION","CARS","ARLO","BCE","CTXR","AMLX","CHH","BW","CMPS","LNT","ATXS","TCPC","ALIT","ABCL","CNQ","RCEL","BBD","COP","AGO","CCEC","CDTX","CLAR","DDS","AKAM","CLFD","AVTX","BILL","AVPT","IPSC","CVRX","LNG","ALXO","ATHM","CRNX","CIM","ABEV","CROX","ADVM"],"gpt_icon":1},{"id":"2533833965","title":"ALX Oncology Holdings Inc  expected to post a loss of 46 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2533833965","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533833965?lang=en_us&edition=fundamental","pubTime":"2025-05-05 19:26","pubTimestamp":1746444366,"startTime":"0","endTime":"0","summary":"ALX Oncology Holdings Inc  expected to post a loss of46cents a share - Earnings Preview ALX Oncology Holdings Inc ALXO.OQ ALXO.O is expected to show no change in quarterly revenue when it reports  res","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250505:nL8N3RD0N9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALXO"],"gpt_icon":0},{"id":"2530034285","title":"LifeSci Capital Reaffirms Their Hold Rating on ALX Oncology Holdings (ALXO)","url":"https://stock-news.laohu8.com/highlight/detail?id=2530034285","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530034285?lang=en_us&edition=fundamental","pubTime":"2025-04-28 21:35","pubTimestamp":1745847355,"startTime":"0","endTime":"0","summary":"LifeSci Capital analyst Sam Slutsky maintained a Hold rating on ALX Oncology Holdings (ALXO – Research Report) today. The company’s shares opened t...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/lifesci-capital-reaffirms-their-hold-rating-on-alx-oncology-holdings-alxo?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/lifesci-capital-reaffirms-their-hold-rating-on-alx-oncology-holdings-alxo?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ALX","ALXO"],"gpt_icon":0},{"id":"2530163491","title":"ALX Oncology Phase 1/2 Evorpacept Trial to Treat B-cell Non-Hodgkin Lymphoma Shows Anti-tumor Activity","url":"https://stock-news.laohu8.com/highlight/detail?id=2530163491","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530163491?lang=en_us&edition=fundamental","pubTime":"2025-04-26 01:44","pubTimestamp":1745603098,"startTime":"0","endTime":"0","summary":"ALX Oncology  said Friday that data from its ongoing phase 1/2 trial of its evorpacept investigational drug in combination with rituximab and lenalidomide in patients with indolent and aggressive relapsed or refractory B-cell non-Hodgkin lymphoma showed anti-tumor activity.A median follow-up of 28 months on the patients revealed that the two-year progression-free survival rate was 69% and the two-year overall survival rate was 84%, while 80% achieved complete responses, the company said.The complete response rate was higher than that of patients who received the standard-of-care rituximab and lenalidomide treatment, the company said.The phase 2 portion of the study in patients with previously untreated indolent non-Hodgkin lymphoma is ongoing and has completed enrollment, the company added.Shares of the company were down 9.3% in recent Friday trading.Price: 0.55, Change: -0.06, Percent Change: -9.32","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4080","BK4231","BK4139","ALX","ALXO"],"gpt_icon":0},{"id":"2530150074","title":"ALX Oncology reports ‘encouraging’ final results from Phase 1 evorpacept trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2530150074","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530150074?lang=en_us&edition=fundamental","pubTime":"2025-04-26 01:15","pubTimestamp":1745601358,"startTime":"0","endTime":"0","summary":"ALX Oncology (ALXO) announced “encouraging” data from an ongoing Phase 1/2 investigator-sponsored trial of the company’s lead clinical candidate, e...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/alx-oncology-reports-encouraging-final-results-from-phase-1-evorpacept-trial?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/alx-oncology-reports-encouraging-final-results-from-phase-1-evorpacept-trial?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","ALXO","BK4080","ALX","BK4231"],"gpt_icon":0},{"id":"2530501851","title":"ALX Oncology Announces Encouraging Final Results From Phase 1 Trial Evaluating Evorpacept in Combination With Standard-of-Care Treatment in Patients With B-Cell Non-Hodgkin Lymphoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2530501851","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530501851?lang=en_us&edition=fundamental","pubTime":"2025-04-26 01:10","pubTimestamp":1745601000,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250425:nTUABTG6CN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ALXO"],"gpt_icon":0},{"id":"2530685901","title":"ALX Oncology Announces Encouraging Final Results from Phase 1 Trial Evaluating Evorpacept in Combination with Standard-of-Care Treatment in Patients with B-cell Non-Hodgkin Lymphoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2530685901","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530685901?lang=en_us&edition=fundamental","pubTime":"2025-04-26 01:10","pubTimestamp":1745601000,"startTime":"0","endTime":"0","summary":"- Data to be presented at AACR 2025 Annual Meeting suggest the combination of ALX Oncology’s investigational CD47-blocker, evorpacept, plus rituximab and lenalidomide  was well-tolerated and demonstrated promising anti-tumor activity. - Combination generated complete responses  in 83% of patients with indolent relapsed or refractory B-cell non-Hodgkin lymphoma  comparing favorably to 34% historical CR rate with R2 alone. - Phase 2 portion of trial in patients with previously untreated indolent NHL  is ongoing and has completed enrollment. After a median follow-up of 28 months  the two-year progression-free survival  rate was 69% and two-year overall survival  rate was 84%. Sixteen patients (80%) achieved complete responses and the best overall response rate  was 90%. As previously repo","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/alx-oncology-announces-encouraging-final-171000715.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ALX","BK4124","PFS","BK4139","BK4211","ALXO","OS","ORR","CR","BK4097","BK4080","SMP","BK4231","BK4161","BK4195"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":1,"totalSize":73,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ALXO\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-08","symbol":"ALXO","fiscalQuarterEnding":"2025/03","expectedEps":-0.47,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1746676800000,"reportTimeType":"pre","actualEps":-0.58},{"market":"US","date":"2025-03-06","symbol":"ALXO","fiscalQuarterEnding":"2024/12","expectedEps":-0.68,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1741237200000,"reportTimeType":"post","actualEps":-0.55},{"market":"US","date":"2024-11-07","symbol":"ALXO","fiscalQuarterEnding":"2024/09","expectedEps":-0.78,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1730955600000,"reportTimeType":"post","actualEps":-0.58},{"market":"US","date":"2024-08-08","symbol":"ALXO","fiscalQuarterEnding":"2024/06","expectedEps":-0.77,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1723089600000,"reportTimeType":"post","actualEps":-0.76},{"market":"US","date":"2024-05-09","symbol":"ALXO","fiscalQuarterEnding":"2024/03","expectedEps":-0.87,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1715227200000,"reportTimeType":"post","actualEps":-0.71}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ALXO\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ALXO\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.1667,"buy":0.6667,"hold":0.1667,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6667,"analysts":6,"updateTime":1741320000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ALXO\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ALXO","date":"2025-06-05","current":-0.219534,"percent":0.970516,"low":-127.638043,"twenty":-46.483414,"median":-4.216736,"eighty":-1.547944,"high":-0.168113,"avg":-19.357881,"sd":27.742727,"marketCap":28544451},"quantilePoints":[{"date":"2020-07-17","current":-51.632367,"twenty":-44.059627,"median":-32.700517,"eighty":-27.964215,"marketCap":1056346590},{"date":"2020-07-24","current":-53.947809,"twenty":-53.555461,"median":-52.280454,"eighty":-40.273257,"marketCap":1103718228},{"date":"2020-07-31","current":-58.317136,"twenty":-57.311299,"median":-53.32362,"eighty":-51.859549,"marketCap":1193110283},{"date":"2020-08-07","current":-78.808386,"twenty":-66.642041,"median":-55.659872,"eighty":-52.264427,"marketCap":1612340777},{"date":"2020-08-14","current":-81.037635,"twenty":-77.25683,"median":-58.138796,"eighty":-52.603126,"marketCap":1657948968},{"date":"2020-08-21","current":-80.377777,"twenty":-78.451707,"median":-66.360264,"eighty":-53.109612,"marketCap":1644448943},{"date":"2020-08-28","current":-59.283293,"twenty":-78.408905,"median":-67.769149,"eighty":-53.573296,"marketCap":1635803910},{"date":"2020-09-04","current":-57.595227,"twenty":-78.255533,"median":-59.223005,"eighty":-54.040246,"marketCap":1589225086},{"date":"2020-09-11","current":-52.825768,"twenty":-77.995157,"median":-58.89477,"eighty":-53.969912,"marketCap":1457621427},{"date":"2020-09-18","current":-50.052516,"twenty":-77.72408,"median":-58.138796,"eighty":-52.854002,"marketCap":1381099075},{"date":"2020-09-25","current":-52.343464,"twenty":-77.370967,"median":-57.307184,"eighty":-52.397352,"marketCap":1444313192},{"date":"2020-10-02","current":-46.395038,"twenty":-77.292498,"median":-55.933955,"eighty":-52.226272,"marketCap":1280178291},{"date":"2020-10-09","current":-47.774966,"twenty":-77.014288,"median":-54.527039,"eighty":-50.69023,"marketCap":1318254631},{"date":"2020-10-16","current":-57.742597,"twenty":-76.461434,"median":-54.058325,"eighty":-50.071272,"marketCap":1593291492},{"date":"2020-10-23","current":-55.947352,"twenty":-75.765908,"median":-54.902164,"eighty":-50.229361,"marketCap":1543755283},{"date":"2020-10-30","current":-52.932947,"twenty":-72.07784,"median":-54.674603,"eighty":-50.69023,"marketCap":1460578813},{"date":"2020-11-06","current":-61.62783,"twenty":-67.205595,"median":-54.902164,"eighty":-51.215407,"marketCap":1700496720},{"date":"2020-11-13","current":-54.256262,"twenty":-65.197086,"median":-55.356773,"eighty":-51.333096,"marketCap":1884319967},{"date":"2020-11-20","current":-79.001733,"twenty":-69.838643,"median":-55.779885,"eighty":-51.745958,"marketCap":2743730176},{"date":"2020-11-27","current":-73.20001,"twenty":-73.20001,"median":-55.940653,"eighty":-52.200323,"marketCap":2542236332},{"date":"2020-12-04","current":-78.232443,"twenty":-77.149826,"median":-56.444567,"eighty":-52.330066,"marketCap":2717012760},{"date":"2020-12-11","current":-91.41367,"twenty":-77.809683,"median":-57.106223,"eighty":-52.343464,"marketCap":3174796768},{"date":"2020-12-18","current":-95.406578,"twenty":-78.398205,"median":-57.742597,"eighty":-52.360584,"marketCap":3313470449},{"date":"2020-12-24","current":-101.693591,"twenty":-78.672443,"median":-57.88912,"eighty":-52.379042,"marketCap":3531818430},{"date":"2020-12-31","current":-98.894264,"twenty":-79.717412,"median":-58.317136,"eighty":-52.480117,"marketCap":3434597796},{"date":"2021-01-08","current":-98.664811,"twenty":-81.501149,"median":-58.89477,"eighty":-52.560501,"marketCap":3426628892},{"date":"2021-01-15","current":-95.601613,"twenty":-87.560076,"median":-59.283293,"eighty":-52.611411,"marketCap":3320244018},{"date":"2021-01-22","current":-93.4677,"twenty":-92.198654,"median":-61.62783,"eighty":-52.71323,"marketCap":3246133207},{"date":"2021-01-29","current":-90.920771,"twenty":-92.818347,"median":-64.414983,"eighty":-52.86864,"marketCap":3157678368},{"date":"2021-02-05","current":-91.918892,"twenty":-92.818347,"median":-67.769149,"eighty":-52.946544,"marketCap":3192343102},{"date":"2021-02-12","current":-93.811879,"twenty":-92.93078,"median":-71.292813,"eighty":-53.076598,"marketCap":3258086563},{"date":"2021-02-19","current":-100.443072,"twenty":-93.460816,"median":-73.177512,"eighty":-53.251804,"marketCap":3488387901},{"date":"2021-02-26","current":-92.113927,"twenty":-93.460816,"median":-75.475824,"eighty":-53.300465,"marketCap":3199116671},{"date":"2021-03-05","current":-78.725341,"twenty":-93.759105,"median":-76.81098,"eighty":-53.358023,"marketCap":2734131099},{"date":"2021-03-12","current":-88.511514,"twenty":-93.531946,"median":-77.381667,"eighty":-53.551905,"marketCap":3074004872},{"date":"2021-03-19","current":-55.330616,"twenty":-93.460816,"median":-77.595675,"eighty":-53.798417,"marketCap":2530822377},{"date":"2021-03-26","current":-57.725615,"twenty":-93.382802,"median":-77.149826,"eighty":-53.896889,"marketCap":2640369628},{"date":"2021-04-01","current":-65.077297,"twenty":-93.180883,"median":-76.418632,"eighty":-53.947809,"marketCap":2976635547},{"date":"2021-04-09","current":-55.944718,"twenty":-92.985848,"median":-74.108199,"eighty":-54.058325,"marketCap":2558911416},{"date":"2021-04-16","current":-53.27776,"twenty":-92.939958,"median":-72.516197,"eighty":-53.495636,"marketCap":2436924734},{"date":"2021-04-23","current":-55.155158,"twenty":-92.917012,"median":-68.342322,"eighty":-53.294676,"marketCap":2522796938},{"date":"2021-04-30","current":-55.111578,"twenty":-92.882594,"median":-65.454531,"eighty":-53.32362,"marketCap":2520803591},{"date":"2021-05-07","current":-57.152096,"twenty":-92.848176,"median":-65.014338,"eighty":-53.495636,"marketCap":2614136887},{"date":"2021-05-14","current":-48.726164,"twenty":-92.721977,"median":-63.919275,"eighty":-53.294676,"marketCap":2228734742},{"date":"2021-05-21","current":-40.258673,"twenty":-92.653141,"median":-63.17505,"eighty":-52.94439,"marketCap":2192930159},{"date":"2021-05-28","current":-41.772712,"twenty":-92.263071,"median":-61.62783,"eighty":-52.571219,"marketCap":2275401390},{"date":"2021-06-04","current":-40.517167,"twenty":-92.143756,"median":-60.822445,"eighty":-52.379042,"marketCap":2207010613},{"date":"2021-06-11","current":-44.062235,"twenty":-91.957899,"median":-60.25961,"eighty":-52.086732,"marketCap":2400113984},{"date":"2021-06-18","current":-43.788969,"twenty":-91.78122,"median":-59.283293,"eighty":-50.873988,"marketCap":2385228933},{"date":"2021-06-25","current":-42.27493,"twenty":-91.480296,"median":-59.109127,"eighty":-50.078046,"marketCap":2302757701},{"date":"2021-07-02","current":-41.285265,"twenty":-91.377297,"median":-58.667015,"eighty":-49.378663,"marketCap":2248849677},{"date":"2021-07-09","current":-41.706242,"twenty":-91.34067,"median":-58.164259,"eighty":-48.538615,"marketCap":2271780702},{"date":"2021-07-16","current":-40.251287,"twenty":-91.104251,"median":-57.987212,"eighty":-47.965726,"marketCap":2192527860},{"date":"2021-07-23","current":-44.305958,"twenty":-90.936013,"median":-57.742597,"eighty":-46.338892,"marketCap":2413389841},{"date":"2021-07-30","current":-43.249823,"twenty":-90.466454,"median":-57.394267,"eighty":-44.85692,"marketCap":2355861128},{"date":"2021-08-06","current":-49.113956,"twenty":-89.509635,"median":-57.10274,"eighty":-45.119846,"marketCap":2675286288},{"date":"2021-08-13","current":-45.262916,"twenty":-88.805214,"median":-56.707355,"eighty":-45.130443,"marketCap":2689250914},{"date":"2021-08-20","current":-42.492549,"twenty":-88.557404,"median":-55.947352,"eighty":-44.982206,"marketCap":2524652298},{"date":"2021-08-27","current":-50.973404,"twenty":-88.256821,"median":-55.900461,"eighty":-45.082566,"marketCap":3028533845},{"date":"2021-09-03","current":-48.868468,"twenty":-88.066375,"median":-55.679405,"eighty":-45.130443,"marketCap":2903471172},{"date":"2021-09-10","current":-52.759205,"twenty":-88.038841,"median":-55.330616,"eighty":-45.198345,"marketCap":3134635404},{"date":"2021-09-17","current":-52.833896,"twenty":-87.975981,"median":-55.194935,"eighty":-45.273044,"marketCap":3139073112},{"date":"2021-09-24","current":-50.912293,"twenty":-87.775903,"median":-55.111578,"eighty":-45.344367,"marketCap":3024902994},{"date":"2021-10-01","current":-50.518467,"twenty":-87.47246,"median":-54.984083,"eighty":-45.527983,"marketCap":3001504171},{"date":"2021-10-08","current":-41.548723,"twenty":-87.079132,"median":-54.929153,"eighty":-45.344367,"marketCap":2468575809},{"date":"2021-10-15","current":-40.054897,"twenty":-86.164209,"median":-54.475312,"eighty":-45.077267,"marketCap":2379821654},{"date":"2021-10-22","current":-36.70058,"twenty":-84.954992,"median":-54.178901,"eighty":-44.359134,"marketCap":2180528231},{"date":"2021-10-29","current":-38.051813,"twenty":-84.221162,"median":-53.915984,"eighty":-43.969177,"marketCap":2260810399},{"date":"2021-11-05","current":-34.602434,"twenty":-83.375712,"median":-53.495636,"eighty":-43.582173,"marketCap":2055868986},{"date":"2021-11-12","current":-25.205542,"twenty":-82.343867,"median":-53.311679,"eighty":-43.170059,"marketCap":1860143780},{"date":"2021-11-19","current":-21.001874,"twenty":-81.732906,"median":-53.27776,"eighty":-42.526625,"marketCap":1549917319},{"date":"2021-11-26","current":-18.433576,"twenty":-80.942444,"median":-53.091921,"eighty":-42.023386,"marketCap":1360379481},{"date":"2021-12-03","current":-16.106742,"twenty":-80.524899,"median":-52.985295,"eighty":-41.694425,"marketCap":1188661440},{"date":"2021-12-10","current":-17.056134,"twenty":-80.373956,"median":-52.932947,"eighty":-41.567457,"marketCap":1258725641},{"date":"2021-12-17","current":-13.110394,"twenty":-80.254576,"median":-52.792486,"eighty":-41.255723,"marketCap":967533962},{"date":"2021-12-23","current":-12.764661,"twenty":-79.838188,"median":-52.604712,"eighty":-40.856903,"marketCap":942019253},{"date":"2021-12-31","current":-11.793318,"twenty":-79.289904,"median":-52.535131,"eighty":-40.627951,"marketCap":870335071},{"date":"2022-01-07","current":-10.53112,"twenty":-79.001733,"median":-52.37212,"eighty":-40.450697,"marketCap":777186134},{"date":"2022-01-14","current":-10.152461,"twenty":-78.808386,"median":-52.330066,"eighty":-40.369456,"marketCap":749241453},{"date":"2022-01-21","current":-8.473189,"twenty":-78.74195,"median":-52.195625,"eighty":-40.147016,"marketCap":625312866},{"date":"2022-01-28","current":-8.341481,"twenty":-78.655834,"median":-51.618626,"eighty":-39.843604,"marketCap":615592977},{"date":"2022-02-04","current":-7.507333,"twenty":-78.517591,"median":-51.204689,"eighty":-39.21928,"marketCap":554033679},{"date":"2022-02-11","current":-8.231725,"twenty":-78.430306,"median":-50.897527,"eighty":-38.45245,"marketCap":607493070},{"date":"2022-02-18","current":-8.231725,"twenty":-78.401772,"median":-50.803651,"eighty":-37.275023,"marketCap":607493070},{"date":"2022-02-25","current":-9.246971,"twenty":-78.298748,"median":-50.561615,"eighty":-36.737247,"marketCap":682417215},{"date":"2022-03-04","current":-8.095702,"twenty":-78.117892,"median":-50.477726,"eighty":-35.075026,"marketCap":675691617},{"date":"2022-03-11","current":-8.825922,"twenty":-77.950932,"median":-50.246862,"eighty":-26.858361,"marketCap":736637945},{"date":"2022-03-18","current":-9.736263,"twenty":-77.842025,"median":-50.16538,"eighty":-24.334226,"marketCap":812617700},{"date":"2022-03-25","current":-8.738296,"twenty":-77.552873,"median":-50.084428,"eighty":-20.659434,"marketCap":729324385},{"date":"2022-04-01","current":-8.850263,"twenty":-77.349566,"median":-49.785034,"eighty":-18.326015,"marketCap":738669489},{"date":"2022-04-08","current":-8.241746,"twenty":-77.221162,"median":-49.531736,"eighty":-17.51711,"marketCap":687880883},{"date":"2022-04-14","current":-7.793878,"twenty":-76.878749,"median":-49.323406,"eighty":-16.89589,"marketCap":650500468},{"date":"2022-04-22","current":-7.018746,"twenty":-76.450733,"median":-49.062508,"eighty":-13.33759,"marketCap":585805636},{"date":"2022-04-29","current":-6.229137,"twenty":-76.041509,"median":-48.76637,"eighty":-12.649417,"marketCap":519902502},{"date":"2022-05-06","current":-5.12271,"twenty":-75.292049,"median":-48.533182,"eighty":-12.244416,"marketCap":427556752},{"date":"2022-05-13","current":-4.189039,"twenty":-74.289836,"median":-48.498423,"eighty":-12.034782,"marketCap":392977948},{"date":"2022-05-20","current":-3.794419,"twenty":-73.182011,"median":-48.249313,"eighty":-11.086487,"marketCap":355958286},{"date":"2022-05-27","current":-3.490866,"twenty":-72.899487,"median":-48.0929,"eighty":-10.458681,"marketCap":327481623},{"date":"2022-06-03","current":-3.295724,"twenty":-72.026844,"median":-47.774966,"eighty":-9.81182,"marketCap":309175197},{"date":"2022-06-10","current":-2.942301,"twenty":-69.838643,"median":-47.421347,"eighty":-9.247467,"marketCap":276020225},{"date":"2022-06-17","current":-2.805702,"twenty":-68.686227,"median":-46.559829,"eighty":-9.18227,"marketCap":263205727},{"date":"2022-06-24","current":-3.469184,"twenty":-67.769149,"median":-46.395038,"eighty":-9.098538,"marketCap":325447576},{"date":"2022-07-01","current":-3.568923,"twenty":-65.99845,"median":-45.687745,"eighty":-8.994531,"marketCap":334804193},{"date":"2022-07-08","current":-4.228067,"twenty":-65.563315,"median":-45.3584,"eighty":-8.846368,"marketCap":396639233},{"date":"2022-07-15","current":-4.492593,"twenty":-65.297717,"median":-45.155297,"eighty":-8.814531,"marketCap":421454610},{"date":"2022-07-22","current":-5.051999,"twenty":-65.11354,"median":-44.961089,"eighty":-8.736349,"marketCap":473933032},{"date":"2022-07-29","current":-4.197712,"twenty":-64.976563,"median":-44.438898,"eighty":-8.619165,"marketCap":393791566},{"date":"2022-08-05","current":-4.973942,"twenty":-64.743307,"median":-44.265338,"eighty":-8.538703,"marketCap":466610462},{"date":"2022-08-12","current":-5.356359,"twenty":-64.073678,"median":-43.907138,"eighty":-8.41026,"marketCap":591647383},{"date":"2022-08-19","current":-5.112888,"twenty":-63.886724,"median":-43.707728,"eighty":-8.340383,"marketCap":564754320},{"date":"2022-08-26","current":-4.887862,"twenty":-63.433892,"median":-43.456619,"eighty":-8.230808,"marketCap":539898611},{"date":"2022-09-02","current":-4.921063,"twenty":-63.086449,"median":-43.183353,"eighty":-8.158015,"marketCap":543565847},{"date":"2022-09-09","current":-4.82515,"twenty":-62.661917,"median":-42.84731,"eighty":-7.986968,"marketCap":532971610},{"date":"2022-09-16","current":-4.493144,"twenty":-61.944008,"median":-42.492549,"eighty":-7.729088,"marketCap":496299251},{"date":"2022-09-23","current":-3.611485,"twenty":-61.460423,"median":-42.033813,"eighty":-7.54782,"marketCap":398913766},{"date":"2022-09-30","current":-3.530328,"twenty":-61.032994,"median":-41.772712,"eighty":-7.202887,"marketCap":389949412},{"date":"2022-10-07","current":-3.692642,"twenty":-60.743489,"median":-41.658236,"eighty":-6.707777,"marketCap":407878120},{"date":"2022-10-14","current":-4.054159,"twenty":-60.626043,"median":-41.588073,"eighty":-6.066342,"marketCap":447810244},{"date":"2022-10-21","current":-4.319764,"twenty":-60.194965,"median":-41.442844,"eighty":-5.374091,"marketCap":477148131},{"date":"2022-10-28","current":-4.61488,"twenty":-59.641614,"median":-41.248337,"eighty":-5.193368,"marketCap":509745783},{"date":"2022-11-04","current":-4.504211,"twenty":-59.348016,"median":-40.938144,"eighty":-5.122179,"marketCap":497521663},{"date":"2022-11-11","current":-4.300453,"twenty":-59.217202,"median":-40.687035,"eighty":-5.030256,"marketCap":521262231},{"date":"2022-11-18","current":-3.537198,"twenty":-59.166887,"median":-40.572559,"eighty":-4.96312,"marketCap":428747355},{"date":"2022-11-25","current":-3.590996,"twenty":-59.119845,"median":-40.463886,"eighty":-4.89524,"marketCap":435268227},{"date":"2022-12-02","current":-3.816274,"twenty":-58.926924,"median":-40.435144,"eighty":-4.797114,"marketCap":462574380},{"date":"2022-12-09","current":-3.614533,"twenty":-58.707207,"median":-40.376841,"eighty":-4.756536,"marketCap":438121109},{"date":"2022-12-16","current":-3.506937,"twenty":-58.527063,"median":-40.251287,"eighty":-4.709417,"marketCap":425079364},{"date":"2022-12-23","current":-3.745664,"twenty":-58.255985,"median":-40.054897,"eighty":-4.634062,"marketCap":454015735},{"date":"2022-12-30","current":-3.789375,"twenty":-58.159166,"median":-39.906151,"eighty":-4.595265,"marketCap":459313944},{"date":"2023-01-06","current":-3.68178,"twenty":-58.138796,"median":-39.727822,"eighty":-4.504211,"marketCap":446272199},{"date":"2023-01-13","current":-3.365718,"twenty":-58.085303,"median":-39.240083,"eighty":-4.478389,"marketCap":407962074},{"date":"2023-01-20","current":-3.036207,"twenty":-57.928357,"median":-39.017899,"eighty":-4.414536,"marketCap":368021731},{"date":"2023-01-27","current":-3.086643,"twenty":-57.857645,"median":-38.302211,"eighty":-4.350751,"marketCap":374135049},{"date":"2023-02-03","current":-2.931974,"twenty":-57.764033,"median":-37.31848,"eighty":-4.296199,"marketCap":355387541},{"date":"2023-02-10","current":-2.747045,"twenty":-57.729011,"median":-37.155517,"eighty":-4.239666,"marketCap":332972042},{"date":"2023-02-17","current":-2.56884,"twenty":-57.621305,"median":-36.70058,"eighty":-4.223535,"marketCap":311371653},{"date":"2023-02-24","current":-2.205705,"twenty":-57.354074,"median":-35.54626,"eighty":-4.200241,"marketCap":267355765},{"date":"2023-03-03","current":-2.192256,"twenty":-57.16858,"median":-33.651476,"eighty":-4.170666,"marketCap":265725547},{"date":"2023-03-10","current":-1.783676,"twenty":-57.122482,"median":-27.791947,"eighty":-4.074467,"marketCap":220251834},{"date":"2023-03-17","current":-1.578503,"twenty":-57.05258,"median":-25.006111,"eighty":-4.025988,"marketCap":194916743},{"date":"2023-03-24","current":-1.542102,"twenty":-56.989742,"median":-23.916278,"eighty":-3.955655,"marketCap":190421808},{"date":"2023-03-31","current":-1.495773,"twenty":-56.654797,"median":-21.770169,"eighty":-3.901832,"marketCap":184700981},{"date":"2023-04-06","current":-1.449443,"twenty":-56.409431,"median":-20.145775,"eighty":-3.885205,"marketCap":178980154},{"date":"2023-04-14","current":-1.638069,"twenty":-56.204581,"median":-19.081139,"eighty":-3.85326,"marketCap":202272092},{"date":"2023-04-21","current":-1.654616,"twenty":-55.946825,"median":-18.126258,"eighty":-3.798897,"marketCap":204315245},{"date":"2023-04-28","current":-1.846551,"twenty":-55.942565,"median":-17.484184,"eighty":-3.767184,"marketCap":228015813},{"date":"2023-05-05","current":-2.101362,"twenty":-55.920558,"median":-17.017719,"eighty":-3.734905,"marketCap":259480361},{"date":"2023-05-12","current":-1.984089,"twenty":-55.832135,"median":-16.422292,"eighty":-3.693832,"marketCap":256211317},{"date":"2023-05-19","current":-1.902097,"twenty":-55.690123,"median":-13.17076,"eighty":-3.654578,"marketCap":245623501},{"date":"2023-05-26","current":-2.060341,"twenty":-55.614879,"median":-12.846979,"eighty":-3.612095,"marketCap":266058068},{"date":"2023-06-01","current":-2.11098,"twenty":-55.421299,"median":-12.572588,"eighty":-3.599066,"marketCap":272597130},{"date":"2023-06-09","current":-2.51292,"twenty":-55.335847,"median":-12.314661,"eighty":-3.56863,"marketCap":324500931},{"date":"2023-06-16","current":-3.025632,"twenty":-55.275002,"median":-12.21588,"eighty":-3.5537,"marketCap":390708930},{"date":"2023-06-23","current":-2.281884,"twenty":-55.245267,"median":-12.034782,"eighty":-3.543223,"marketCap":294666463},{"date":"2023-06-30","current":-2.319862,"twenty":-55.202891,"median":-11.793318,"eighty":-3.523749,"marketCap":299570759},{"date":"2023-07-07","current":-2.003373,"twenty":-55.149894,"median":-11.261,"eighty":-3.507192,"marketCap":258701624},{"date":"2023-07-14","current":-2.250235,"twenty":-55.125388,"median":-10.786303,"eighty":-3.491733,"marketCap":290579549},{"date":"2023-07-21","current":-2.155288,"twenty":-55.099265,"median":-10.410388,"eighty":-3.446634,"marketCap":278318809},{"date":"2023-07-28","current":-1.803986,"twenty":-55.039457,"median":-9.925154,"eighty":-3.375531,"marketCap":232954069},{"date":"2023-08-04","current":-1.788161,"twenty":-54.991977,"median":-9.278658,"eighty":-3.333018,"marketCap":230910612},{"date":"2023-08-11","current":-1.590872,"twenty":-54.964509,"median":-9.227764,"eighty":-3.228425,"marketCap":207405167},{"date":"2023-08-18","current":-1.43936,"twenty":-54.936896,"median":-9.186164,"eighty":-3.186841,"marketCap":187652294},{"date":"2023-08-25","current":-1.417265,"twenty":-54.918358,"median":-9.156556,"eighty":-3.13237,"marketCap":184771667},{"date":"2023-09-01","current":-1.344666,"twenty":-54.835061,"median":-9.069329,"eighty":-3.106144,"marketCap":175306748},{"date":"2023-09-08","current":-1.568777,"twenty":-54.674603,"median":-9.025516,"eighty":-3.086643,"marketCap":204524540},{"date":"2023-09-15","current":-1.581403,"twenty":-54.276021,"median":-8.934523,"eighty":-3.025632,"marketCap":206170613},{"date":"2023-09-22","current":-1.584559,"twenty":-54.256262,"median":-8.83079,"eighty":-2.959169,"marketCap":206582131},{"date":"2023-09-29","current":-1.562464,"twenty":-54.178901,"median":-8.819987,"eighty":-2.922787,"marketCap":203701504},{"date":"2023-10-06","current":-2.439673,"twenty":-54.058325,"median":-8.780507,"eighty":-2.805702,"marketCap":318065046},{"date":"2023-10-13","current":-3.610879,"twenty":-53.947809,"median":-8.733428,"eighty":-2.875086,"marketCap":470757533},{"date":"2023-10-20","current":-2.69383,"twenty":-53.884159,"median":-8.640933,"eighty":-2.875086,"marketCap":351200064},{"date":"2023-10-27","current":-2.644157,"twenty":-53.841288,"median":-8.62136,"eighty":-2.8031,"marketCap":344724035},{"date":"2023-11-03","current":-2.942198,"twenty":-53.664443,"median":-8.578747,"eighty":-2.767568,"marketCap":383580212},{"date":"2023-11-10","current":-2.995692,"twenty":-53.494397,"median":-8.480285,"eighty":-2.780558,"marketCap":390554398},{"date":"2023-11-17","current":-3.046261,"twenty":-53.424971,"median":-8.422523,"eighty":-2.799034,"marketCap":444881991},{"date":"2023-11-24","current":-3.015559,"twenty":-53.318844,"median":-8.370743,"eighty":-2.802233,"marketCap":440398298},{"date":"2023-12-01","current":-2.674433,"twenty":-53.298726,"median":-8.341481,"eighty":-2.802233,"marketCap":390579486},{"date":"2023-12-08","current":-3.155421,"twenty":-53.291293,"median":-8.236735,"eighty":-2.798257,"marketCap":460824011},{"date":"2023-12-15","current":-4.49946,"twenty":-53.270425,"median":-8.227142,"eighty":-2.802233,"marketCap":657110130},{"date":"2023-12-22","current":-4.44488,"twenty":-53.211253,"median":-8.17522,"eighty":-2.810832,"marketCap":649139120},{"date":"2023-12-29","current":-5.21412,"twenty":-53.121754,"median":-8.095702,"eighty":-2.826221,"marketCap":761480541},{"date":"2024-01-05","current":-4.455113,"twenty":-53.072909,"median":-8.065863,"eighty":-2.834762,"marketCap":650633684},{"date":"2024-01-12","current":-4.792829,"twenty":-53.028094,"median":-7.880505,"eighty":-2.853962,"marketCap":699954308},{"date":"2024-01-19","current":-4.352776,"twenty":-52.996307,"median":-7.737821,"eighty":-2.875208,"marketCap":635688041},{"date":"2024-01-26","current":-4.939513,"twenty":-52.96243,"median":-7.643702,"eighty":-2.875697,"marketCap":721376397},{"date":"2024-02-02","current":-5.116899,"twenty":-52.942101,"median":-7.507333,"eighty":-2.879044,"marketCap":747282180},{"date":"2024-02-09","current":-4.71437,"twenty":-52.913137,"median":-7.309163,"eighty":-2.897551,"marketCap":688495981},{"date":"2024-02-16","current":-5.727516,"twenty":-52.83227,"median":-7.018746,"eighty":-2.918978,"marketCap":836457853},{"date":"2024-02-23","current":-5.475082,"twenty":-52.825768,"median":-6.740921,"eighty":-2.922787,"marketCap":799591932},{"date":"2024-03-01","current":-5.004327,"twenty":-52.759205,"median":-6.282752,"eighty":-2.931974,"marketCap":730841972},{"date":"2024-03-08","current":-5.031296,"twenty":-52.638205,"median":-5.931816,"eighty":-2.942198,"marketCap":809057506},{"date":"2024-03-15","current":-3.477477,"twenty":-52.571219,"median":-5.60471,"eighty":-2.942198,"marketCap":559195714},{"date":"2024-03-22","current":-3.901636,"twenty":-52.544424,"median":-5.543307,"eighty":-2.942301,"marketCap":627402545},{"date":"2024-03-28","current":-3.558566,"twenty":-52.53699,"median":-5.410268,"eighty":-2.944036,"marketCap":572235255},{"date":"2024-04-05","current":-3.505546,"twenty":-52.476531,"median":-5.405151,"eighty":-2.956229,"marketCap":563709401},{"date":"2024-04-12","current":-4.172973,"twenty":-52.399301,"median":-5.385913,"eighty":-2.97616,"marketCap":671034857},{"date":"2024-04-19","current":-4.909013,"twenty":-52.365198,"median":-5.336925,"eighty":-2.983672,"marketCap":789393770},{"date":"2024-04-26","current":-5.297814,"twenty":-52.346888,"median":-5.304714,"eighty":-2.990242,"marketCap":851915025},{"date":"2024-05-03","current":-5.219305,"twenty":-52.332746,"median":-5.310685,"eighty":-2.99489,"marketCap":839290321},{"date":"2024-05-10","current":-5.150088,"twenty":-52.226272,"median":-5.297814,"eighty":-2.995826,"marketCap":855954931},{"date":"2024-05-17","current":-4.595538,"twenty":-52.196565,"median":-5.232916,"eighty":-3.00889,"marketCap":763787568},{"date":"2024-05-24","current":-4.604942,"twenty":-51.815379,"median":-5.21412,"eighty":-3.012566,"marketCap":765350571},{"date":"2024-05-31","current":-3.332235,"twenty":-51.667547,"median":-5.190766,"eighty":-3.014404,"marketCap":553824137},{"date":"2024-06-07","current":-2.824406,"twenty":-51.615878,"median":-5.146845,"eighty":-2.994087,"marketCap":469421964},{"date":"2024-06-14","current":-2.523471,"twenty":-51.396921,"median":-5.133955,"eighty":-2.953289,"marketCap":419405861},{"date":"2024-06-21","current":-2.056393,"twenty":-51.236842,"median":-5.12271,"eighty":-2.942198,"marketCap":341776701},{"date":"2024-06-28","current":-1.890252,"twenty":-51.112175,"median":-5.115194,"eighty":-2.912637,"marketCap":314163645},{"date":"2024-07-05","current":-1.708437,"twenty":-50.961182,"median":-5.109776,"eighty":-2.875697,"marketCap":283945583},{"date":"2024-07-12","current":-2.213131,"twenty":-50.906387,"median":-5.081423,"eighty":-2.825795,"marketCap":367826755},{"date":"2024-07-19","current":-1.927869,"twenty":-50.873988,"median":-5.038774,"eighty":-2.798257,"marketCap":320415658},{"date":"2024-07-26","current":-1.896521,"twenty":-50.831847,"median":-5.031296,"eighty":-2.760148,"marketCap":315205647},{"date":"2024-08-02","current":-0.896537,"twenty":-50.794145,"median":-5.016014,"eighty":-2.734048,"marketCap":149006306},{"date":"2024-08-09","current":-0.793162,"twenty":-50.71722,"median":-5.014561,"eighty":-2.708922,"marketCap":135981279},{"date":"2024-08-16","current":-0.780359,"twenty":-50.558417,"median":-4.997808,"eighty":-2.674037,"marketCap":133786346},{"date":"2024-08-23","current":-0.734275,"twenty":-50.540195,"median":-4.963392,"eighty":-2.642976,"marketCap":125885578},{"date":"2024-08-30","current":-0.712769,"twenty":-50.502171,"median":-4.948317,"eighty":-2.612107,"marketCap":122198552},{"date":"2024-09-06","current":-0.586806,"twenty":-50.436985,"median":-4.937807,"eighty":-2.56884,"marketCap":100603118},{"date":"2024-09-13","current":-0.682046,"twenty":-50.301183,"median":-4.915634,"eighty":-2.53191,"marketCap":116931373},{"date":"2024-09-20","current":-0.635962,"twenty":-50.246862,"median":-4.910618,"eighty":-2.507797,"marketCap":109030605},{"date":"2024-09-27","current":-0.605239,"twenty":-50.185751,"median":-4.905401,"eighty":-2.404084,"marketCap":103763426},{"date":"2024-10-04","current":-0.516143,"twenty":-50.178961,"median":-4.889809,"eighty":-2.343562,"marketCap":88488607},{"date":"2024-10-11","current":-0.473131,"twenty":-50.1518,"median":-4.867583,"eighty":-2.319862,"marketCap":81114556},{"date":"2024-10-18","current":-0.454698,"twenty":-50.146298,"median":-4.856379,"eighty":-2.304038,"marketCap":77954249},{"date":"2024-10-25","current":-0.451625,"twenty":-50.084428,"median":-4.82515,"eighty":-2.246054,"marketCap":77427531},{"date":"2024-11-01","current":-0.445481,"twenty":-50.052516,"median":-4.797783,"eighty":-2.195618,"marketCap":76374095},{"date":"2024-11-08","current":-0.505941,"twenty":-49.812294,"median":-4.792829,"eighty":-2.17586,"marketCap":76477500},{"date":"2024-11-15","current":-0.450113,"twenty":-49.757774,"median":-4.779917,"eighty":-2.156705,"marketCap":68038604},{"date":"2024-11-22","current":-0.491984,"twenty":-49.67739,"median":-4.758749,"eighty":-2.148545,"marketCap":74367776},{"date":"2024-11-29","current":-0.516409,"twenty":-49.560867,"median":-4.75541,"eighty":-2.140096,"marketCap":78059793},{"date":"2024-12-06","current":-0.565258,"twenty":-49.365072,"median":-4.734631,"eighty":-2.113511,"marketCap":85443828},{"date":"2024-12-13","current":-0.505941,"twenty":-49.323406,"median":-4.71437,"eighty":-2.107947,"marketCap":76477500},{"date":"2024-12-20","current":-0.565258,"twenty":-49.285832,"median":-4.708903,"eighty":-2.095409,"marketCap":85443828},{"date":"2024-12-27","current":-0.565258,"twenty":-49.178949,"median":-4.684322,"eighty":-2.063954,"marketCap":85443828},{"date":"2025-01-03","current":-0.631554,"twenty":-49.072798,"median":-4.662836,"eighty":-2.056707,"marketCap":95465018},{"date":"2025-01-10","current":-0.617597,"twenty":-48.982542,"median":-4.635911,"eighty":-2.03169,"marketCap":93355294},{"date":"2025-01-17","current":-0.607129,"twenty":-48.848048,"median":-4.61488,"eighty":-2.005467,"marketCap":91773000},{"date":"2025-01-24","current":-0.528621,"twenty":-48.76637,"median":-4.605341,"eighty":-1.985539,"marketCap":79905802},{"date":"2025-01-31","current":-0.50943,"twenty":-48.726164,"median":-4.594142,"eighty":-1.94957,"marketCap":77004931},{"date":"2025-02-07","current":-0.380328,"twenty":-48.56541,"median":-4.557451,"eighty":-1.927869,"marketCap":57489983},{"date":"2025-02-14","current":-0.383817,"twenty":-48.500955,"median":-4.538639,"eighty":-1.902097,"marketCap":58017414},{"date":"2025-02-21","current":-0.390796,"twenty":-48.498929,"median":-4.511686,"eighty":-1.885007,"marketCap":59072276},{"date":"2025-02-28","current":-0.383817,"twenty":-48.498423,"median":-4.496929,"eighty":-1.861402,"marketCap":58017414},{"date":"2025-03-07","current":-0.419631,"twenty":-48.444833,"median":-4.49091,"eighty":-1.84135,"marketCap":56587193},{"date":"2025-03-14","current":-0.328618,"twenty":-48.303038,"median":-4.468755,"eighty":-1.815444,"marketCap":44314178},{"date":"2025-03-21","current":-0.279925,"twenty":-48.236339,"median":-4.454794,"eighty":-1.787264,"marketCap":37747928},{"date":"2025-03-28","current":-0.25934,"twenty":-48.213399,"median":-4.441499,"eighty":-1.751836,"marketCap":34971953},{"date":"2025-04-04","current":-0.204233,"twenty":-48.116285,"median":-4.391678,"eighty":-1.697673,"marketCap":27540880},{"date":"2025-04-11","current":-0.19398,"twenty":-48.023478,"median":-4.369832,"eighty":-1.649321,"marketCap":26158231},{"date":"2025-04-17","current":-0.217733,"twenty":-47.867428,"median":-4.352776,"eighty":-1.635773,"marketCap":29361279},{"date":"2025-04-25","current":-0.214494,"twenty":-47.765754,"median":-4.330512,"eighty":-1.611596,"marketCap":28924488},{"date":"2025-05-02","current":-0.211009,"twenty":-47.622334,"median":-4.300453,"eighty":-1.593193,"marketCap":28454605},{"date":"2025-05-09","current":-0.17358,"twenty":-47.399454,"median":-4.274354,"eighty":-1.588431,"marketCap":22569409},{"date":"2025-05-16","current":-0.179787,"twenty":-46.89039,"median":-4.262759,"eighty":-1.580553,"marketCap":23376414},{"date":"2025-05-23","current":-0.196845,"twenty":-46.579656,"median":-4.239269,"eighty":-1.56562,"marketCap":25594341},{"date":"2025-05-30","current":-0.192036,"twenty":-46.538101,"median":-4.230236,"eighty":-1.56057,"marketCap":24969046},{"date":"2025-06-05","current":-0.219534,"twenty":-46.483414,"median":-4.216736,"eighty":-1.547944,"marketCap":28544451}],"updateTime":1749258989115}}}